Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
PFIZER INC
Pfizer Inc. CEO Albert Bourla filed a Form 4 report on October 16, 2026, disclosing changes in his beneficial ownership of company securities as of October 15, 2026. This filing serves as a standard notification of insider equity activity.…more
PFIZER INC
Pfizer Inc. and Pfizer Ventures (US) LLC have jointly filed a Schedule 13G report. This filing confirms that both entities have entered into a Joint Filing Agreement to report their collective shareholding status.…more
PFIZER INC
Pfizer Inc. CEO Albert Bourla filed a Form 4 report regarding his beneficial ownership of securities as of October 13, 2026. This filing serves as an official disclosure of insider stock transactions.…more
21 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Roche Halts German Investments Amid Policy Dispute, Expands China Partnership…more
Roche has suspended all future investment decisions in Germany due to government-mandated drug price cuts. Simultaneously, the company announced a major collaboration with Hansoh Pharmaceutical for ADC drug development.…more
●●●●●●●● ●●●●● ●●●●●●
Pfizer announced that the FDA has approved TUKYSA in combination with trastuzumab and pertuzumab as a first-line maintenance treatment for HER2+ metastatic breast cancer. This approval provides a new chemotherapy-free option that helps delay disease progression in patients.…more
●●●●●●●● ●●●●● ●●●●●●
The Florida Attorney General has filed a lawsuit against Pfizer, alleging the company concealed critical safety risks and made deceptive claims regarding its COVID-19 vaccine. This legal action targets the company's marketing practices and executive statements, potentially creating ongoing legal headwinds.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.